Results 31 to 40 of about 12,187 (203)
, 2019 Intravenous neostigmine is a well-established treatment for acute colonic pseudo-obstruction (ACPO). Its use is hampered by the perceived requirement for continuous cardiac monitoring, and patients are often transferred to high-dependency units for close
Gillespie, Christopher +10 more
core +1 more source
Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex
, 2021 Purpose/Background: Postoperative nausea and vomiting (PONV) is a frequent complaint in the postoperative period, which can delay discharge, result in readmission, and increase cost for patients and facilities. Inducing paralysis is common in anesthesia,
James, Colton Bradley +4 more
core +1 more source
Pediatric Anesthesia, EarlyView.ABSTRACT Background Neostigmine is widely used to reverse nondepolarizing neuromuscular blockade in children, but the optimal dose under total intravenous anesthesia is uncertain. Aims The primary aim was to compare the time to full neuromuscular recovery (TOF ratio of 1.0) following administration of neostigmine at doses of 0, 10, 20, and 30 μg/kg in ...
Antonio J. M. M. Neto +7 more
wiley +1 more source
Comparison of Sugammadex and Neostigmine in Terms of Time to Extubation in Pediatrics
, 2016 Aim: Sugammadex is a cyclodextrin compound which provides complete recovery of residual neuromuscular blockade. In this study, we compared sugammadex and neostigmine in terms of time to achieve a train-of-four (TOF) ratio of 0.9 and extubation time (TE).
Kaya, Guner +9 more
core +1 more source
Retrospective chart review: sugammadex vs. neostigmine/glycopyrrolate a pharmacoeconomic analysis
, 2020 Purpose of Project: To ascertain the cost-effectiveness of sugammadex versus neostigmine by comparing operating room (OR) and post-anesthesia care unit (PACU) discharge times, that is, who leaves the OR and PACU faster. The overarching goal was to bring
core +1 more source
BMC Anesthesiology, 2020 Background Sugammadex reduces postoperative complications. We sought to determine whether it could reduce the length of hospital stay, post-anesthetic recovery time, unplanned readmission, and charges for patients who underwent robot-assisted ...
Byung-Hun Min +3 more
doaj +1 more source
Pediatric Anesthesia, EarlyView.ABSTRACT Background Objective neuromuscular monitoring is essential to prevent residual neuromuscular block in patients receiving neuromuscular blocking agents. However, the small size of pediatric hands and the lack of appropriately sized neuromuscular equipment have made quantitative neuromuscular monitoring at the ulnar nerve (UN) difficult. In such
Sarah Sofie Wadland +8 more
wiley +1 more source
BMC Anesthesiology, 2010 Background Acetylcholinesterase inhibitors cannot rapidly reverse profound neuromuscular block. Sugammadex, a selective relaxant binding agent, reverses the effects of rocuronium and vecuronium by encapsulation.
Lemmens Hendrikus JM +4 more
doaj +1 more source
International Journal of Analytical Chemistry, 2021 Neostigmine methylsulfate is an anticholinesterase agent and is clinically used for treating myasthenia gravis. It is also used for reversing nondepolarising neuromuscular blocking agents.
Manali Parab +3 more
doaj +1 more source
Pediatric Anesthesia, EarlyView.ABSTRACT Introduction Emergence agitation (EA) is a postoperative neurobehavioral complication characterized by a transient disturbance in cognition and perception following anesthesia. Neuroinflammation is thought to play a central role in its pathophysiology.
Nezahat Merve Ata Soylu +6 more
wiley +1 more source